Background. beta-Endorphin is an endogenous opioid involved in the regulati
on of food intake and obesity as well as in insulin metabolism, In this stu
dy, we investigated glucose-induced beta-endorphin, insulin, and glucose re
sponsiveness in morbidly obese patients and the effect of surgically induce
d weight loss,
Methods. Thirty-two healthy, nondiabetic, morbidly obese patients (body mas
s index over 40 kg/m(2)) and 32 normal-weight controls were studied. Serum
levels of P-endorphin, insulin, and glucose were measured under basal condi
tions and during an oral glucose tolerance test (OGTT) before and 12 months
following vertical banded gastroplasty.
Results. Preoperative basal levels of beta-endorphin, insulin, and glucose
and their responses during OGTT in obese patients were significantly higher
compared with those of controls. After surgery, basal beta-endorphin, insu
lin, and glucose levels decreased significantly compared with preoperative
values. Postoperative basal insulin and glucose levels were similar to thos
e in controls, while beta-endorphin levels remained significantly higher th
an those of controls. A significant reduction in total responses of beta-en
dorphin, insulin, and glucose during OGTT was also observed; however, posto
perative beta-endorphin and insulin responses remained significantly higher
than in controls.
Conclusion. Morbidly obese patients have an increased glucose-stimulated re
sponse of beta-endorphin, insulin, and glucose which is partially corrected
with weight loss following vertical banded gastroplasty. (C) 1998 Academic
Press.